Evaluation of the Hypoglycaemia Notification Device Hyposafe H02
Evaluation of the Hypoglycaemia Notification Device Hyposafe H02 - the Pilot 2 Study - in Subjects With Type 1 Diabetes
Sponsor: UNEEG Medical A/S
Terminated
Slow recruitment
Other terminated trials from UNEEG Medical A/S
More terminations from UNEEG Medical A/S
Other Diabetes Mellitus, Type 1 trials with similar outcome
A NA clinical study on Diabetes Mellitus, Type 1, this trial is terminated or withdrawn. The trial is conducted by UNEEG Medical A/S and has accumulated 12 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Aug 2024 — Sep 2024 [monthly]
Terminated NA
-
Jul 2024 — Aug 2024 [monthly]
Terminated NA
-
May 2021 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting · Phase: EARLY_PHASE1 → NA
-
Oct 2019 — Dec 2020 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2018 — Oct 2019 [monthly]
Recruiting EARLY_PHASE1
-
Feb 2018 — Jun 2018 [monthly]
Recruiting EARLY_PHASE1
-
Nov 2017 — Feb 2018 [monthly]
Recruiting EARLY_PHASE1
-
Feb 2017 — Nov 2017 [monthly]
Recruiting EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting Phase 0
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- UNEEG Medical A/S
For direct contact, visit the study record on ClinicalTrials.gov .